港股異動 | “建滔系”齊漲 產品加價改善毛利率 獲大行看好
格隆匯11月19日丨“建滔系”齊漲,建滔積層板(1888.HK)現報8.87港元,漲8.04%,暫成交8791萬港元,最新總市值273億港元。建滔集團(0148.HK)現報22.1港元,漲3.51%,暫成交2062萬港元,最新總市值244億港元。花旗今日發研報指,由於建滔積層板最近對產品加價改善毛利率以及明年產能擴張步伐高於預期,上調其2020至2021年盈利預測3%,升目標價至11港元,維持“買入”評級,重申其為內地中型股首選名單之一。此外,建滔集團近期產品售價上調後,公司覆銅面板和印刷線路板業務毛利較預期為佳。將其2019-2021財年的盈利預測上調3%-6%,升建滔集團目標價至28港元,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.